Study Stopped
Additional country (Nigeria) has been added to original country, Pakistan. Therefore, an updated protocol has been submitted (NCT06081842)
Strengthening Contraceptive Counseling in Pakistan
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2022
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2021
CompletedFirst Posted
Study publicly available on registry
June 7, 2021
CompletedStudy Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 17, 2024
May 1, 2024
2.9 years
May 24, 2021
May 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in clients' decision-making autonomy
Person-Centered Contraceptive Counseling scale (PCCC), developed and tested by Dehlendorf et al. (2021)
Through study completion, an average of 1 year
Change in clients' met need for family planning
number of participants who want to avoid a pregnancy and are using a contraceptive method / all participants
Through study completion, an average of 1 year
Secondary Outcomes (1)
Change in modern contraceptive prevalence
6 months and 12 months post enrollment
Study Arms (3)
Control arm
OTHERroutine contraceptive counseling and care and a range of family planning methods that are routinely available at field level
Intervention package
EXPERIMENTALcontraceptive counseling package but still with a range of family planning methods that are routinely available at field level
Intervention package & expanded methods
EXPERIMENTALcontraceptive counseling package but with an expanded range of family planning methods that are recommended by national guidance
Interventions
The implementation package will be co-designed by providers and clients during the formative and research design phases
Expanded range of contraceptive methods as recommended by national policies
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Nguyen-Toan Tranlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- World Health Organization consultant
Study Record Dates
First Submitted
May 24, 2021
First Posted
June 7, 2021
Study Start
January 1, 2022
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
May 17, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Supporting information will become available 6 months after data collection and will be available for at least 3 years
- Access Criteria
- Upon reasonable request from the World Health Organization
(i) use of a controlled access approach, such as upon reasonable request from the World Health Organization; (ii) the trial will seek consent for sharing IPD from trial participants with adequate assurance that patient privacy and confidentiality will be maintained